ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullishSamsung C&T
04 Nov 2017 22:10

Samsung Restructuring Update - New Scenario Attracts Local Institutions

Last week, we heard a couple of major news from Samsung Electronics Co Ltd (005930 KS). First, SamE made headlines with its new 3-year shareholder...

Logo
491 Views
Share
bullishSK Telecom
09 Oct 2017 03:05

SK Group Restructuring - Local Institutions Are Already Making A Move

We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...

Logo
356 Views
Share
05 Oct 2017 22:59

Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?

Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...

Logo
1k Views
Share
04 Oct 2017 00:25

Biosimilar Battlefield: U.S. Humira Pushed to 2023

We are updating our market model to reflect the patent litigation settlement between Amgen Inc (AMGN US) and Abbvie Inc (ABBV US) , the...

Share
bearishCelltrion Inc
24 Sep 2017 03:44

Biosimilar Battlefield: Celltrion Forecasts

This Insight uses the biosimilar market model discussed in Surveying The Biosimilar Battlefield to build a long-term revenue forecast for the...

Share
x